2 completed, 1 not yet recruiting. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 2, Not yet recruiting 1 |
Follow Thrombolysis: new trials by email Literature Review of Thrombolysis trials Research Report on Thrombolysis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tenecteplase vs Medical Management in 4.5-24h LVO no Access to EVT TNK, Standard medical treatment - Acute Ischemic Stroke, Large Vessel Occlusion | Phase 3 | Not yet recruiting | The First Affiliated Hospital of University of Science and Technology of China | 794 | 2025-11-01 | 2025-09-11 |
| Endovascular Treatment With or Without Preceding Intravenous Tenecteplase (TNK) in Patients With Late-window acUte Ischemic Stroke Due to Middle Cerebral Artery Occlusion Tenecteplase, direct EVT - Ischemic Stroke, Acute, Thrombolysis | Phase 3 | Completed | Beijing Tiantan Hospital | 391 | 2024-01-25 | 2025-11-26 |
| Tenecteplase in Stroke Patients Between 4.5 and 24 Hours Tenecteplase, Placebo - THROMBOLYSIS | Phase 3 | Completed | Genentech, Inc. | 458 | 2019-03-02 | 2024-05-22 |
Ischemic Stroke (2) · Infarction, Middle Cerebral Artery (1)
Brain Diseases (2) · Cardiovascular Diseases (2) · Central Nervous System Diseases (2) · Cerebrovascular Disorders (2) · Nervous System Diseases (2) · Stroke (2) · Vascular Diseases (2) · Brain Infarction (1) · Brain Ischemia (1) · Cerebral Arterial Diseases (1) · Cerebral Infarction (1) · Infarction (1) · Intracranial Arterial Diseases (1) · Ischemia (1) · Necrosis (1)
Tenecteplase (3)
Beijing Tiantan Hospital (1) · Genentech, Inc. (1) · The First Affiliated Hospital of University of Science and Technology of China (1)
China (2) · Canada (1) · United States (1)
Fengyuan Che, MD (1) · Yunyun Xiong, MD (1)